Activities per year
Activities
A new algorithm based on thrombin generation to assess hormone-relatedprothrombotic changes
Jonathan Douxfils (Invited speaker)
9 Jul 2019
Activity: Talk or presentation types › Oral presentation
Laboratory testing in patients treated with DOACs: a practical guide for clinicians
Jonathan Douxfils (Invited speaker)
20 Jun 2019
Activity: Talk or presentation types › Oral presentation
Clinical Debate: There is a need for DOAC testing in emergency situations and elective preoperative setting - YES
Jonathan Douxfils (Invited speaker)
14 Jun 2019
Activity: Talk or presentation types › Oral presentation
Affections thromboemboliques veineuses – partie II
Jonathan Douxfils (Keynote speaker)
12 Mar 2019
Activity: Talk or presentation types › Oral presentation
Mécanismes thrombotiques des inhibiteurs de tyrosine kinase ciblant BCR-ABL
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
21 Mar 2019
Activity: Talk or presentation types › Oral presentation
Belgian College of Neuropsychopharmacology and Biological Psychiatry, annual symposium
Martin Desseilles (Speaker)
14 Dec 2018
Activity: Talk or presentation types › Oral presentation
Educational I - Should we measure DOACs?
Jonathan Douxfils (Invited speaker)
22 Nov 2018
Activity: Talk or presentation types › Oral presentation
Interference of DOACs in coagulation tests
Jonathan Douxfils (Invited speaker)
9 Nov 2018
Activity: Talk or presentation types › Oral presentation
Spin-off et financement - Présentation de QUALIblood
Damien Gheldof (Speaker), & Jonathan Douxfils (Speaker)
6 Mar 2018
Activity: Talk or presentation types › Oral presentation
Risques thrombotiques des produits dérivéssanguinsRevue de la littérature
Adeline Wannez (Speaker)
29 Mar 2018
Activity: Talk or presentation types › Oral presentation
DOACs: new test on development
Jonathan Douxfils (Speaker)
2 Mar 2018
Activity: Talk or presentation types › Oral presentation
In vitro effects of BCR-ABL TKIs on endothelial cell survival and functions
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), , François Mullier (Speaker), & Jean-Michel Dogne (Speaker)
9 Feb 2018
Activity: Talk or presentation types › Oral presentation
Nanoparticules dans les peintures: quels risques pour la santé?
Julie Laloy (Speaker)
2018
Activity: Talk or presentation types › Oral presentation
Réunion des tuteurs de Stage en médecine Générale - La réforme des études de bachelier en médecine
Éric Marchand (Speaker)
18 Oct 2017
Activity: Talk or presentation types › Oral presentation
Assessment of thrombin generation in plasma samples of patients under anticoagulant treatment with ST Genesia system using STG – DrugScreen
Jonathan Douxfils (Speaker)
29 Jun 2017
Activity: Talk or presentation types › Oral presentation
JOURNÉE DES PROJETS PUNCH- Classe inversée en Faculté de Médecine
Éric Marchand (Speaker)
16 May 2017
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
25 Feb 2017
Activity: Talk or presentation types › Oral presentation
A GOLD 3 COPD patient "cured" by endobronchial valves
Éric Marchand (Speaker)
2 Dec 2016
Activity: Talk or presentation types › Oral presentation
Analysis of extracellular vesicles derived from blood by flow cytometry
Adeline Wannez (Speaker)
27 May 2016
Activity: Talk or presentation types › Oral presentation
Hémoglobinurie paroxystique nocturne: un modèle de la thrombogénicité
Adeline Wannez (Speaker)
28 Apr 2016
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
28 Apr 2016
Activity: Talk or presentation types › Oral presentation
Risk of vascular occlusive events with BCR-ABL TKIs in CML - A systematic review and meta-analysis
Hélène Haguet (Speaker), , Jonathan Douxfils (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
29 Jan 2016
Activity: Talk or presentation types › Oral presentation
Extracellular vesicle and platelet analysis by flow cytometry
Adeline Wannez (Speaker)
2016
Activity: Talk or presentation types › Oral presentation
Neurophysiologie du rêve et régulation des émotions
Martin Desseilles (Speaker)
30 Nov 2015
Activity: Talk or presentation types › Oral presentation
Neurosciences et psychiatrie : parallélisme ou convergence ?
Martin Desseilles (Speaker)
2 Oct 2015
Activity: Talk or presentation types › Oral presentation
Risk of cardiovascular events associated with BCR-ABL TKI in leukemic population: a systematic review and meta-analysis
Jonathan Douxfils (Speaker), , Hélène Haguet (Speaker), , François Mullier (Speaker), , Christian Chatelain (Speaker), , Carlos Graux (Speaker), & Jean-Michel Dogne (Speaker)
Jun 2015
Activity: Talk or presentation types › Oral presentation
Hemocompatibility of nanoparticles: impact on fibrinolysis.
Julie Laloy (Speaker)
2014
Activity: Talk or presentation types › Oral presentation
Effect of dabigatran etexilate on the risk of myocardial infarction and other cardiac events: A systematic review and updated dose-response meta-analysis of randomized controlled trials
Jonathan Douxfils (Speaker)
1 Jul 2013
Activity: Talk or presentation types › Oral presentation
Hemocompatibility of manufactured nanoparticles: Guidelines proposal.
Julie Laloy (Speaker)
2013
Activity: Talk or presentation types › Oral presentation
Impact of nanomaterials on human health: Strategies of the Namur Nanosafety Center (NNC).
Julie Laloy (Speaker)
2012
Activity: Talk or presentation types › Oral presentation
Assessment of different methods studying the impact of carbon nanomaterials on platelet function.
Julie Laloy (Speaker)
2012
Activity: Talk or presentation types › Oral presentation